5-hydroxythiabendazole

thiabendazole metabolite

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Alhanti, Brooke: 1 article (01/2022)
2.	Córdoba Gamboa, Leonel: 1 article (01/2022)
3.	Hoppin, Jane A: 1 article (01/2022)
4.	Lindh, Christian H: 1 article (01/2022)
5.	Mora, Ana M: 1 article (01/2022)
6.	Quirós Lépiz, Marcela: 1 article (01/2022)
7.	Reich, Brian: 1 article (01/2022)
8.	Soto Martinez, Manuel: 1 article (01/2022)
9.	van Wendel de Joode, Berna: 1 article (01/2022)

1.	Fascioliasis 09/01/1994 - "In sheep receiving a 50 mg.kg-1 oral dose of thiabendazole, fascioliasis provoked only decreased plasma concentrations of the metabolite 5-hydroxythiabendazole by Weeks 4 to 25 postinfection. "
2.	Asthma (Bronchial Asthma) 01/01/2022 - "High urinary levels of 5-hydroxythiabendazole (thiabendazole metabolite) and living in a neighbourhood with frequent smoke from waste burning were associated with a high asthma score (OR=1.84 (95%CI=1.05 to 3.25) and OR=2.31 (95%CI=1.11 to 5.16), respectively). "